title: [Management of Chinese materia medica market based on information asymmetry].
abstract: Pharmaceutical market is a typical market with information asymmetry, and which can lead to "lemons" problem. In all developed countries, firms must receive regulatory approval to market a pharmaceutical product. Such administrative department including SFDA, EMA, FDA and so on. Chinese materia medica is a special part of pharmaceutical market in China. The management of Chinese materia medica is a special challenge in China.
authors.forename: Guang
authors.initials: G
authors.lastname: Yang
authors.forename: Nuo
authors.initials: N
authors.lastname: Wang
authors.forename: Lan-Ping
authors.initials: LP
authors.lastname: Guo
authors.forename: Yong-Yan
authors.initials: YY
authors.lastname: Wang
authors.forename: Lu-Qi
authors.initials: LQ
authors.lastname: Huang
authors.forename: Jin-Xin
authors.initials: JX
authors.lastname: Liu
mesh_terms: D000068:Accreditation; D008419:Materia Medica / Q000191:economics* / Q000592:standards; D008516:Medicine, Chinese Traditional / Q000191:economics* / Q000592:standards; D012015:Reference Standards; D012926:Social Control, Formal
chemical_list: D008419:Materia Medica